Justia Forms Business Contracts Categories Business Operations RESEARCH PHARMACEUTICAL SERVICES, INC.

RESEARCH PHARMACEUTICAL SERVICES, INC. Business Operations Contracts & Agreements

28 Contracts & Agreements

Browse by Subcategory

Development Agreements (28 contracts)

Recent Contracts

Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on November 23, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)